" rel="stylesheet">
Skip Main Navigation
Page Content
This event has ended

Xconomy Forum: Reinventing Biotech's Business Model, San Francisco Style

Tuesday, October 16, 2012 at 1:00 PM (PDT)

Xconomy Forum: Reinventing Biotech's Business Model,...

Ticket Information

Ticket Type Sales End Price Fee Quantity
Regular Registration Ended $295.00 $0.00
Startup Special
For employees of startups less than 3 years old with 20 or fewer employees.
Ended $175.00 $0.00
Student Registration
Limited number available. Valid student ID must be shown at registration desk.
Ended $35.00 $0.00
At the Door Ended $375.00 $0.00

Share Xconomy Forum: Reinventing Biotech's Business Model, San Francisco Style

Event Details

Xconomy Forum: Reinventing Biotech's Business Model, San Francico Style

Biotech companies used to think about how to build enduring companies with soup-to-nuts operations that had everything under one corporate flag, from research to development to manufacturing to marketing. Those models increasingly look like relics. Investors have grown weary of the long timelines, big bucks, and high risk that come with building such organizations. Stung by losses, a number of VCs, entrepreneurs and investors are turning to small core teams that lean heavily on contract firms to try to make biotech more nimble, less capital intensive, and a more attractive industry for investment. Come join Xconomy’s half-day forum for a number of case studies and interactive chats with national leaders who are looking to reinvent the biotech business model.

Confirmed Speakers:

Brian Atwood, Managing Director, Versant Ventures
Robert Blum, CEO, Cytokinetics
Tony Coles, CEO, Onyx Pharmaceuticals

Jens Eckstein, President, SR One

Mark Goldsmith, CEO, Global Blood Therapeutics; Venture Partner, Third Rock Ventures
Steve Kaldor, CEO, Quanticel; Venture Partner, Versant Ventures
Richard Lindberg, Executive Director, Head of the Centers for Therapeutic Innovation - California
, Pfizer Inc.
Diego Miralles, Head of West Coast research center, Janssen Labs

Mike Morrissey, CEO, Exelixis
Clare Ozawa, Chief Business Officer, Inception Sciences

Deepa Pakianathan, General Partner, Delphi Ventures
James Sabry, VP of Partnering, Genentech
Risa Stack, Partner, Kleiner Perkins Caufield & Byers

Peter Thompson, Venture Partner, OrbiMed Advisors

Luke Timmerman, National Biotechnology Editor, Xconomy (moderator)

Full agenda



Registration & Networking: 1:00 - 2:00 pm

Program: 2:00 - 6:00 pm

Networking reception: 6:00 - 7:00 pm

Tickets are transferable but not refundable.
To inquire about press registration, email events@xconomy.com.



Onyx Pharmaceuticals 


Recap by Deloitte
Kilpatrick Townsend            Silicon Valley Bank



California Healthcare Institute             Mendelspod

Alexandria Real Estate Equities • Cubist Pharmaceuticals • IDA Ireland • Kauffman Foundation
Kilpatrick Townsend • Latham & WatkinsSilicon Valley Bank • SRI International 

ARCH Venture Partners • Avalon Ventures
Polaris Venture Partners Psilos
SR One 
 • Third Rock Ventures 

Have questions about Xconomy Forum: Reinventing Biotech's Business Model, San Francisco Style? Contact the organizer

When & Where

Onyx Pharmaceuticals
249 E. Grand Avenue
South San Francisco, CA 94080

Tuesday, October 16, 2012 at 1:00 PM (PDT)

  Add to my calendar
Xconomy Forum: Reinventing Biotech's Business Model, San Francisco Style
South San Francisco, CA Events Conference

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.